gi oncology at asco 2022: tumor sidedness, ctdna, and mrd
Published 2 years ago • 249 plays • Length 13:32Download video MP4
Download video MP3
Similar videos
-
58:52
ctdna and mrd | 2023 best of gi cancer conference
-
0:54
highlights in gi cancer at asco 2022
-
46:53
ctdna and mrd: who, when, and then what? | 2022 evolution conference
-
0:31
highlights in colorectal cancer at asco gi 2023
-
4:26
fundamentals of ctdna
-
1:16
colorectal cancer updates at asco 2022
-
2:09
the emerging role of ctdna in the early diagnosis of gi cancers
-
0:45
the emerging role of ctdna in cancer diagnostics
-
1:51
a positive ctdna test after adjuvant therapy: 2023 best of gi
-
1:03:08
young-onset colorectal cancer center annual forum expert panel 2022
-
3:16
the utility of ctdna in colorectal cancer management
-
1:23
role of ctdna in mrd
-
3:43
evolving applications of ctdna in lung cancer: mrd, early detection, and molecular profiling
-
58:58
gi asco 2020 recap webinar
-
1:36
liquid biopsies and tumor-informed ctdna profiling in metastatic urothelial carcinoma
-
15:23
2021 west oncology | gastrointestinal cancers | ctdna analysis in colorectal cancer
-
1:05:21
ctdna and mrd testing | colorectal cancer care tools for surveillance
-
2:13
ongoing clinical trials on using ctdna results to guide gi cancer management
-
6:10
asco 2021 lung recap: circulatory tumor dna